ab56578 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab56578 は 3 報の論文で使用されています。

  • Márk Á  et al. Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease--a combined tissue microarray, in vitro and in vivo study. BMC Cancer 13:250 (2013). IHC-P ; Human . PubMed: 23693095
  • Serrano I  et al. Role of the integrin-linked kinase (ILK)/Rictor complex in TGFß-1-induced epithelial-mesenchymal transition (EMT). Oncogene : (2012). PubMed: 22310280
  • Lamouille S  et al. TGF-ß-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. J Cell Sci 125:1259-73 (2012). PubMed: 22399812

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"